Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spindlin family member 3 (SPIN3) is a human protein belonging to the spindlin/tudor domain family. It possesses a tudor-like domain that enables binding to specific methylated lysine residues on histones, such as H3K4me3, suggesting a potential role in recognizing epigenetic histone modifications[6]. While similar proteins in the family, notably Spindlin-1 (SPIN1), have demonstrated clear roles in transcriptional regulation and oncogenesis through reading histone marks[1], SPIN3’s specific biological function in humans remains poorly understood[3][6]. It is primarily expressed in the nucleus and cytoplasm of various tissues, including the central nervous system[9]. No direct associations with disease, therapeutics, or clinical biomarkers have been reported to date for SPIN3[2][4][6][8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spindlin family member 3 (SPIN3).